This is a preprint.
LAT encodes T cell activation pathway balance
- PMID: 39253472
- PMCID: PMC11383308
- DOI: 10.1101/2024.08.26.609683
LAT encodes T cell activation pathway balance
Abstract
Immune cells transduce environmental stimuli into responses essential for host health via complex signaling cascades. T cells, in particular, leverage their unique T cell receptors (TCRs) to detect specific Human Leukocyte Antigen (HLA)-presented peptides. TCR activation is then relayed via linker for activation of T cells (LAT), a TCR-proximal disordered adapter protein, which organizes protein partners and mediates the propagation of signals down diverse pathways including NFAT and AP-1. Here, we studied how balanced downstream pathway activation is encoded in the amino acid sequence of LAT. To comprehensively profile the sequence-function relationship of LAT, we developed a pooled, single-cell, high-content screening approach in which a large series of mutants in the LAT protein were analyzed to characterize their effects on T cell activation. Measuring epigenetic, transcriptomic, and cell surface protein dynamics of single cells harboring distinct LAT mutants, we found functional regions spanning over 40% of the LAT amino acid sequence. Conserved sequence motifs for protein interactions along with charge distribution are critical sequence features, and contribute to interpretation of human genetic variation in LAT. While mutant defect severity spans from moderate to complete loss of function, nearly all defective mutants, irrespective of their position in LAT, confer balanced defects across all downstream pathways. To understand the molecular basis for this observation, we performed proximal protein labeling which demonstrated that disruption of LAT interaction with a single partner protein indirectly disrupts other partner interactions, likely through the dual roles of these proteins as effectors of downstream pathways and bridging factors between LAT molecules. Overall, we report widely distributed functional regions throughout a disordered adapter and a precise physical organization of LAT and interacting molecules which constrains signaling outputs. More broadly, we describe an approach for interrogating sequence-function relationships for proteins with complex activities across regulatory layers of the cell.
Conflict of interest statement
Competing Interests A.K.S. reports compensation for consulting and/or SAB membership from Honeycomb Biotechnologies, Cellarity, Bio-Rad Laboratories, Fog Pharma, Passkey Therapeutics, Ochre Bio, Relation Therapeutics, IntrECate biotherapeutics, and Dahlia Biosciences unrelated to this work. A.R. is employed by Genentech, Inc., South San Francisco, CA, USA, and is a co-founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas and, until 31 July 2020, was a scientific advisory board member of Thermo Fisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov.
Figures




References
-
- Macián F. et al. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109, 719–731 (2002). - PubMed
-
- Malissen B., Grégoire C., Malissen M. & Roncagalli R. Integrative biology of T cell activation. Nature Immunology 2014 15:9 15, 790–797 (2014). - PubMed
-
- Zhang W. et al. Association of Grb2, Gads, and Phospholipase C-γ1 with Phosphorylated LAT Tyrosine Residues: EFFECT OF LAT TYROSINE MUTATIONS ON T CELL ANTIGEN RECEPTOR-MEDIATED SIGNALING. Journal of Biological Chemistry 275, 23355–23361 (2000). - PubMed
-
- Lin J. & Weiss A. Identification of the Minimal Tyrosine Residues Required for Linker for Activation of T Cell Function. Journal of Biological Chemistry 276, 29588–29595 (2001). - PubMed
References (Methods)
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials